Cerebral energy reserves and glycolysis in neural tissue of 6-aminonicotinamide-treated mice.
D000255:Adenosine Triphosphate / Q000032:analysis; D000588:Amines / Q000494:pharmacology*; D000818:Animals; D001921:Brain / Q000098:blood supply / Q000378:metabolism*; D001923:Brain Chemistry / Q000187:drug effects; D002531:Cerebellum / Q000032:analysis; D004734:Energy Metabolism / Q000187:drug effects*; D005636:Fructosephosphates / Q000032:analysis; D005942:Gluconates / Q000032:analysis; D005947:Glucose / Q000032:analysis; D005958:Glucosephosphates / Q000032:analysis; D006003:Glycogen / Q000032:analysis / Q000378:metabolism; D002534:Hypoxia, Brain / Q000378:metabolism; D007511:Ischemia / Q000378:metabolism; D007523:Isocitrates / Q000032:analysis; D007773:Lactates / Q000032:analysis; D008293:Malates / Q000032:analysis; D051379:Mice; D009243:NAD / Q000032:analysis; D009249:NADP / Q000032:analysis; D009536:Niacinamide / Q000494:pharmacology*; D010725:Phosphocreatine / Q000032:analysis; D012266:Ribose / Q000031:analogs & derivatives / Q000032:analysis
D000588:Amines; D005636:Fructosephosphates; D005942:Gluconates; D005958:Glucosephosphates; D007523:Isocitrates; D007773:Lactates; D008293:Malates; D010725:Phosphocreatine; D009243:NAD; D009536:Niacinamide; D009249:NADP; D012266:Ribose; D000255:Adenosine Triphosphate; D006003:Glycogen; D005947:Glucose